Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Grünenthal GmbH, a global leader in pain management, is seeking a senior strategy consultant with extensive M&A experience to drive external growth. You will work with senior leadership across finance, operations and corporate development, shaping investment theses and enabling strategic decisions.
The role requires 5–8 years in top-tier strategy consulting or corporate finance, a strong pharma background, and proven leadership across global teams.
Select how often (in days) to receive an alert:
Select how often (in days) to receive an alert:
Country: Germany
Department: Corporate Functions
Job ID: 45485
Professional|Permanent|Full-/ Part-time|Hybrid
Our Corporate Functions teams make sure everything at Grünenthal runs smoothly by bringing together people with a wide range of skills – from experts in finance, IT, HR, law and compliance through to business strategists and creative media minds. If you’re a great collaborator and a strong communicator, you’ll feel right at home here. Join our team and join forces with colleagues across our business to maximise our company’s positive impact on patients and their families.
Each day you’ll enjoy a variety of challenges, such as:
To make the most of this role and truly thrive, you should have:
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focussing all of our activities and efforts on working towards our vision of a world free of pain.
Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America and the US. Our products are available in more than 100 countries. In 2024, Grünenthal employed around 4,300 people and achieved sales of € 1.8 billion.